0 XP   0   0   0

PDS Biotechnology Corp
Buy, Hold or Sell?

Let's analyse PDS Biotechnology Corp together

PenkeI guess you are interested in PDS Biotechnology Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of PDS Biotechnology Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about PDS Biotechnology Corp

I send you an email if I find something interesting about PDS Biotechnology Corp.

Quick analysis of PDS Biotechnology Corp (30 sec.)










1. Valuation of PDS Biotechnology Corp (5 min.)




Current price per share

€7.79

2. Growth of PDS Biotechnology Corp (5 min.)




Is PDS Biotechnology Corp growing?

Current yearPrevious yearGrowGrow %
How rich?$43.9m$57m-$7.5m-15.2%

How much money is PDS Biotechnology Corp making?

Current yearPrevious yearGrowGrow %
Making money-$10.2m-$4.2m-$5.9m?
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of PDS Biotechnology Corp (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#592 / 1215

Most Revenue
#1107 / 1215

Most Profit
#678 / 1215

Most Efficient
#496 / 1215


Fundamentals of PDS Biotechnology Corp

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of PDS Biotechnology Corp.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit PDS Biotechnology Corp earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare PDS Biotechnology Corp to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that €0.00 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of PDS Biotechnology Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--194.7%+194.7%
TTM--272.1%+272.1%
YOY--303.9%+303.9%
5Y--539.0%+539.0%
10Y--661.6%+661.6%
1.1.2. Return on Assets

Shows how efficient PDS Biotechnology Corp is using its assets to generate profit.

  • Above 5% is considered healthy but always compare PDS Biotechnology Corp to the Biotechnology industry mean.
  • -24.9% Return on Assets means that PDS Biotechnology Corp generated €-0.25 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of PDS Biotechnology Corp:

  • The MRQ is -24.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -14.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-24.9%TTM-14.8%-10.1%
TTM-14.8%YOY-7.7%-7.0%
TTM-14.8%5Y-14.6%-0.2%
5Y-14.6%10Y-14.6%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-24.9%-12.6%-12.3%
TTM-14.8%-12.6%-2.2%
YOY-7.7%-10.9%+3.2%
5Y-14.6%-15.3%+0.7%
10Y-14.6%-17.7%+3.1%
1.1.3. Return on Equity

Shows how efficient PDS Biotechnology Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare PDS Biotechnology Corp to the Biotechnology industry mean.
  • -43.5% Return on Equity means PDS Biotechnology Corp generated €-0.43 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of PDS Biotechnology Corp:

  • The MRQ is -43.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -21.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-43.5%TTM-21.4%-22.1%
TTM-21.4%YOY-8.4%-13.0%
TTM-21.4%5Y-18.3%-3.1%
5Y-18.3%10Y-18.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-43.5%-15.3%-28.2%
TTM-21.4%-15.6%-5.8%
YOY-8.4%-13.2%+4.8%
5Y-18.3%-20.5%+2.2%
10Y-18.3%-20.9%+2.6%

1.2. Operating Efficiency of PDS Biotechnology Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient PDS Biotechnology Corp is operating .

  • Measures how much profit PDS Biotechnology Corp makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare PDS Biotechnology Corp to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of PDS Biotechnology Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--313.9%+313.9%
TTM--265.1%+265.1%
YOY--331.0%+331.0%
5Y--515.2%+515.2%
10Y--609.4%+609.4%
1.2.2. Operating Ratio

Measures how efficient PDS Biotechnology Corp is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are €0.00 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of PDS Biotechnology Corp:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.013-3.013
TTM-3.644-3.644
YOY-4.501-4.501
5Y-6.353-6.353
10Y-8.330-8.330

1.3. Liquidity of PDS Biotechnology Corp.

1.3. Liquidity
1.3.1. Current Ratio

Measures if PDS Biotechnology Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 7.79 means the company has €7.79 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of PDS Biotechnology Corp:

  • The MRQ is 7.787. The company is very able to pay all its short-term debts. +2
  • The TTM is 11.901. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.787TTM11.901-4.113
TTM11.901YOY16.566-4.665
TTM11.9015Y11.327+0.574
5Y11.32710Y11.3270.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.7874.571+3.216
TTM11.9015.011+6.890
YOY16.5666.142+10.424
5Y11.3276.306+5.021
10Y11.3276.588+4.739
1.3.2. Quick Ratio

Measures if PDS Biotechnology Corp is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare PDS Biotechnology Corp to the Biotechnology industry mean.
  • A Quick Ratio of 0.00 means the company can pay off €0.00 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of PDS Biotechnology Corp:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.923-3.923
TTM-4.516-4.516
YOY-5.772-5.772
5Y-5.816-5.816
10Y-6.032-6.032

1.4. Solvency of PDS Biotechnology Corp.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of PDS Biotechnology Corp assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare PDS Biotechnology Corp to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.43 means that PDS Biotechnology Corp assets are financed with 42.9% credit (debt) and the remaining percentage (100% - 42.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of PDS Biotechnology Corp:

  • The MRQ is 0.429. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.242. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.429TTM0.242+0.187
TTM0.242YOY0.073+0.169
TTM0.2425Y0.157+0.085
5Y0.15710Y0.1570.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4290.311+0.118
TTM0.2420.298-0.056
YOY0.0730.269-0.196
5Y0.1570.377-0.220
10Y0.1570.409-0.252
1.4.2. Debt to Equity Ratio

Measures if PDS Biotechnology Corp is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare PDS Biotechnology Corp to the Biotechnology industry mean.
  • A Debt to Equity ratio of 75.0% means that company has €0.75 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of PDS Biotechnology Corp:

  • The MRQ is 0.750. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.381. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.750TTM0.381+0.369
TTM0.381YOY0.080+0.301
TTM0.3815Y0.211+0.169
5Y0.21110Y0.2110.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7500.362+0.388
TTM0.3810.361+0.020
YOY0.0800.277-0.197
5Y0.2110.425-0.214
10Y0.2110.460-0.249

2. Market Valuation of PDS Biotechnology Corp

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings PDS Biotechnology Corp generates.

  • Above 15 is considered overpriced but always compare PDS Biotechnology Corp to the Biotechnology industry mean.
  • A PE ratio of -20.71 means the investor is paying €-20.71 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of PDS Biotechnology Corp:

  • The EOD is -13.507. Company is losing money. -2
  • The MRQ is -20.711. Company is losing money. -2
  • The TTM is -19.098. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-13.507MRQ-20.711+7.204
MRQ-20.711TTM-19.098-1.613
TTM-19.098YOY-171.009+151.910
TTM-19.0985Y-60.962+41.864
5Y-60.96210Y-60.9620.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-13.507-6.313-7.194
MRQ-20.711-7.248-13.463
TTM-19.098-8.522-10.576
YOY-171.009-19.704-151.305
5Y-60.962-18.354-42.608
10Y-60.962-18.137-42.825
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of PDS Biotechnology Corp.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of PDS Biotechnology Corp:

  • The MRQ is 35.854. Seems overpriced? -1
  • The TTM is -7.871. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ35.854TTM-7.871+43.725
TTM-7.871YOY-90.246+82.375
TTM-7.8715Y-35.923+28.052
5Y-35.92310Y-35.9230.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ35.854-4.301+40.155
TTM-7.871-6.130-1.741
YOY-90.246-13.925-76.321
5Y-35.923-12.463-23.460
10Y-35.923-11.860-24.063

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of PDS Biotechnology Corp is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 9.01 means the investor is paying €9.01 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of PDS Biotechnology Corp:

  • The EOD is 5.875. Seems overpriced? -1
  • The MRQ is 9.008. Seems overpriced? -1
  • The TTM is 4.190. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD5.875MRQ9.008-3.133
MRQ9.008TTM4.190+4.818
TTM4.190YOY4.813-0.624
TTM4.1905Y4.180+0.010
5Y4.18010Y4.1800.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD5.8751.808+4.067
MRQ9.0082.028+6.980
TTM4.1902.338+1.852
YOY4.8133.951+0.862
5Y4.1803.697+0.483
10Y4.1803.952+0.228
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of PDS Biotechnology Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.092-0.145+57%0.272-134%0.095-197%0.095-197%
Book Value Growth--0.9350.914+2%1.439-35%1.186-21%1.186-21%
Book Value Per Share--1.3261.494-11%1.721-23%1.182+12%1.182+12%
Book Value Per Share Growth--0.9350.914+2%1.439-35%1.186-21%1.186-21%
Current Ratio--7.78711.901-35%16.566-53%11.327-31%11.327-31%
Debt To Asset Ratio--0.4290.242+77%0.073+486%0.157+174%0.157+174%
Debt To Equity Ratio--0.7500.381+97%0.080+839%0.211+255%0.211+255%
Dividend Per Share----0%-0%-0%-0%
Eps---0.577-0.308-47%-0.127-78%-0.178-69%-0.178-69%
Eps Growth---0.5780.530-209%-1.419+146%0.128-552%0.128-552%
Free Cash Flow Per Share---0.227-0.194-15%-0.094-59%-0.132-42%-0.132-42%
Free Cash Flow Per Share Growth--0.7220.846-15%-0.218+130%0.413+75%0.413+75%
Free Cash Flow To Equity Per Share--0.0660.065+2%0.642-90%0.360-82%0.360-82%
Free Cash Flow To Equity Per Share Growth--0.1171.735-93%0.781-85%1.524-92%1.524-92%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--15.642--------
Intrinsic Value_10Y_min---2.770--------
Intrinsic Value_1Y_max---0.215--------
Intrinsic Value_1Y_min---0.695--------
Intrinsic Value_3Y_max--0.714--------
Intrinsic Value_3Y_min---1.739--------
Intrinsic Value_5Y_max--3.279--------
Intrinsic Value_5Y_min---2.392--------
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio5.875-53%9.0084.190+115%4.813+87%4.180+116%4.180+116%
Pe Ratio-13.507+35%-20.711-19.098-8%-171.009+726%-60.962+194%-60.962+194%
Peg Ratio--35.854-7.871+122%-90.246+352%-35.923+200%-35.923+200%
Price Per Share7.790-53%11.9456.029+98%8.291+44%4.921+143%4.921+143%
Price To Total Gains Ratio-84.564+35%-129.668-51.141-61%-42.399-67%-29.822-77%-29.822-77%
Profit Growth---0.5780.530-209%-1.419+146%0.128-552%0.128-552%
Quick Ratio----0%-0%-0%-0%
Return On Assets---0.249-0.148-41%-0.077-69%-0.146-41%-0.146-41%
Return On Equity---0.435-0.214-51%-0.084-81%-0.183-58%-0.183-58%
Total Gains Per Share---0.092-0.145+57%0.272-134%0.095-197%0.095-197%
Total Gains Per Share Growth--1.3001.033+26%5.482-76%2.782-53%2.782-53%
Usd Book Value--43983957.92649569489.950-11%57085106.443-23%39207501.471+12%39207501.471+12%
Usd Book Value Change Per Share---0.099-0.156+57%0.293-134%0.102-197%0.102-197%
Usd Book Value Per Share--1.4271.608-11%1.852-23%1.272+12%1.272+12%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.621-0.331-47%-0.137-78%-0.191-69%-0.191-69%
Usd Free Cash Flow---7525840.792-6424786.692-15%-3120234.462-59%-4369084.907-42%-4369084.907-42%
Usd Free Cash Flow Per Share---0.244-0.208-15%-0.101-59%-0.142-42%-0.142-42%
Usd Free Cash Flow To Equity Per Share--0.0710.070+2%0.690-90%0.387-82%0.387-82%
Usd Price Per Share8.383-53%12.8546.487+98%8.921+44%5.295+143%5.295+143%
Usd Profit---19129822.962-10209518.876-47%-4227882.103-78%-5894018.630-69%-5894018.630-69%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.099-0.156+57%0.293-134%0.102-197%0.102-197%
 EOD+3 -2MRQTTM+11 -22YOY+4 -295Y+5 -2810Y+5 -28

3.2. Fundamental Score

Let's check the fundamental score of PDS Biotechnology Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-13.507
Price to Book Ratio (EOD)Between0-15.875
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than17.787
Debt to Asset Ratio (MRQ)Less than10.429
Debt to Equity Ratio (MRQ)Less than10.750
Return on Equity (MRQ)Greater than0.15-0.435
Return on Assets (MRQ)Greater than0.05-0.249
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of PDS Biotechnology Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5066.929
Ma 20Greater thanMa 506.620
Ma 50Greater thanMa 1005.998
Ma 100Greater thanMa 2006.919
OpenGreater thanClose7.790
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets77,008
Total Liabilities33,006
Total Stockholder Equity44,002
 As reported
Total Liabilities 33,006
Total Stockholder Equity+ 44,002
Total Assets = 77,008

Assets

Total Assets77,008
Total Current Assets76,480
Long-term Assets76,480
Total Current Assets
Cash And Cash Equivalents 73,820
Other Current Assets 2,660
Total Current Assets  (as reported)76,480
Total Current Assets  (calculated)76,480
+/-0
Long-term Assets
Long-term Assets  (as reported)528
Long-term Assets  (calculated)0
+/- 528

Liabilities & Shareholders' Equity

Total Current Liabilities9,821
Long-term Liabilities23,185
Total Stockholder Equity44,002
Total Current Liabilities
Accounts payable 1,219
Total Current Liabilities  (as reported)9,821
Total Current Liabilities  (calculated)1,219
+/- 8,602
Long-term Liabilities
Long term Debt 23,021
Capital Lease Obligations Min Short Term Debt452
Long-term Liabilities  (as reported)23,185
Long-term Liabilities  (calculated)23,473
+/- 288
Total Stockholder Equity
Total Stockholder Equity (as reported)44,002
Total Stockholder Equity (calculated)0
+/- 44,002
Other
Capital Stock10
Common Stock Shares Outstanding 30,170
Net Invested Capital 67,023
Net Working Capital 66,659



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
19,383
14,491
23,934
20,093
34,445
30,890
27,762
77,391
71,748
67,198
61,039
56,001
74,887
77,008
77,00874,88756,00161,03967,19871,74877,39127,76230,89034,44520,09323,93414,49119,383
   > Total Current Assets 
18,134
14,470
23,917
19,441
33,842
30,337
27,257
76,934
71,341
66,840
60,731
55,743
74,411
76,480
76,48074,41155,74360,73166,84071,34176,93427,25730,33733,84219,44123,91714,47018,134
       Cash And Cash Equivalents 
17,407
12,162
21,038
16,934
33,469
28,840
25,037
74,749
69,744
65,243
58,881
52,985
71,642
73,820
73,82071,64252,98558,88165,24369,74474,74925,03728,84033,46916,93421,03812,16217,407
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
1,849
2,758
2,769
2,660
2,6602,7692,7581,8490000000000
   > Long-term Assets 
1,250
21
17
652
603
553
505
456
407
358
308
258
475
528
52847525830835840745650555360365217211,250
       Property Plant Equipment 
27
21
17
652
603
553
505
456
407
358
308
258
475
0
0475258308358407456505553603652172127
       Intangible Assets 
1,223
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000001,223
> Total Liabilities 
3,801
2,794
4,047
3,079
3,420
3,761
3,387
4,398
3,891
3,987
5,165
4,576
27,828
33,006
33,00627,8284,5765,1653,9873,8914,3983,3873,7613,4203,0794,0472,7943,801
   > Total Current Liabilities 
3,644
2,794
4,047
2,526
2,899
3,270
2,929
4,003
3,577
3,756
5,018
4,516
4,841
9,821
9,8214,8414,5165,0183,7563,5774,0032,9293,2702,8992,5264,0472,7943,644
       Accounts payable 
1,489
1,198
2,557
1,093
1,560
1,415
951
2,375
1,446
1,309
2,746
1,878
2,037
1,219
1,2192,0371,8782,7461,3091,4462,3759511,4151,5601,0932,5571,1981,489
       Other Current Liabilities 
858
498
270
127
0
0
0
0
0
0
0
0
61
0
06100000000127270498858
   > Long-term Liabilities 
157
0
0
552
522
490
458
395
314
231
147
60
22,987
23,185
23,18522,9876014723131439545849052255200157
       Other Liabilities 
157
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000157
> Total Stockholder Equity
15,583
11,698
19,888
17,014
31,025
27,130
24,374
72,993
67,857
63,210
55,873
51,425
47,059
44,002
44,00247,05951,42555,87363,21067,85772,99324,37427,13031,02517,01419,88811,69815,583
   Common Stock
2
2
5
5
7
7
7
9
9
9
9
9
9
0
09999997775522
   Retained Earnings Total Equity00000000000000
   Accumulated Other Comprehensive Income 00000000000000
   Capital Surplus 00000000000000
   Treasury Stock00000000000000
   Other Stockholders Equity 00000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-41,672
Operating Income-41,672-41,672
 
Operating Expense (+$)
Research Development29,431
Selling General Administrative12,241
Selling And Marketing Expenses-
Operating Expense41,67241,672
 
Net Interest Income (+$)
Interest Income935
Interest Expense-1,317
Other Finance Cost-0
Net Interest Income-381
 
Pretax Income (+$)
Operating Income-41,672
Net Interest Income-381
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-42,054-41,672
EBIT - interestExpense = -1,317
-40,855
-39,538
Interest Expense1,317
Earnings Before Interest and Taxes (EBIT)--40,737
Earnings Before Interest and Taxes (EBITDA)-40,737
 
After tax Income (+$)
Income Before Tax-42,054
Tax Provision--1,199
Net Income From Continuing Ops-40,855-40,855
Net Income-40,855
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-381
 

Technicals of PDS Biotechnology Corp

1. Trend Indicators

1.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

PDS Biotechnology Corp Daily Moving Averages ChartPDS Biotechnology Corp Daily Moving Averages Chart
1.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Let's take a look of the Moving Average Convergence/Divergence (MACD) of PDS Biotechnology Corp:

  • The Moving Average Convergence/Divergence (MACD) is 0.512. The Moving Average Convergence/Divergence (MACD) above zero is a bullish sign. +1
  • The MACD is higher than the signal line. This is a bullish indication. +1
PDS Biotechnology Corp Daily Moving Average Convergence/Divergence (MACD) ChartPDS Biotechnology Corp Daily Moving Average Convergence/Divergence (MACD) Chart
1.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index).

The ADX helps you determine the strength of a trend. Let's take a look of the ADX of PDS Biotechnology Corp:

  • The ADX is 24.448. Absent or Weak Trend. -1
  • The ADX is rising, a new trend could be forming. +1
  • The +DI is higher than the -DI. The current trend is up. +2
PDS Biotechnology Corp Daily Directional Movement Index (DMI) ChartPDS Biotechnology Corp Daily Directional Movement Index (DMI) Chart
1.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..
  • The Parabolic SAR is lower than the price. The current trend is up. +2
  • PDS Biotechnology Corp Daily Parabolic SAR ChartPDS Biotechnology Corp Daily Parabolic SAR Chart

    2. Momentum Indicators

    2.1 Relative Strength Index (RSI)

    Measures the speed and change of price movements.

    • Leading momentum indicator, meaning the signals are instant.
    • Ranges between 0 and 100.
    • Above 70 is considered overbought.
    • Below 30 is considered oversold.
    • Above or below 50 can also be used to determine price trend or support and resistance.
    • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
    • Can be used in many different ways
    • The RSI is above 50. +1
    PDS Biotechnology Corp Daily Relative Strength Index (RSI) ChartPDS Biotechnology Corp Daily Relative Strength Index (RSI) Chart
    2.2 Stochastic Oscillator

    Compares a certain price to multiple prices ranging over time.

    • Leading momentum indicator, meaning the signals are instant.
    • Used to determine overbought and oversold areas much like the RSI.
    • Ranges between 0 and 100.
    • Above 80 is considered overbought.
    • Below 20 is considered oversold.
    • Consists of two lines named K and D.
    • K compares the highest high and lowest low on the selected price range.
    • The D line is a moving average of the K line.
    • Can be used to spot divergences
    • The Stochastic is above 50. +1
    • The Stochastic is above 70 and overbought. +2
    PDS Biotechnology Corp Daily Stochastic Oscillator ChartPDS Biotechnology Corp Daily Stochastic Oscillator Chart
    2.3 Commodity Channel Index (CCI)
    PDS Biotechnology Corp Daily Commodity Channel Index (CCI) ChartPDS Biotechnology Corp Daily Commodity Channel Index (CCI) Chart
    2.4 Chande Momentum Oscillator (CMO)
    PDS Biotechnology Corp Daily Chande Momentum Oscillator (CMO) ChartPDS Biotechnology Corp Daily Chande Momentum Oscillator (CMO) Chart
    2.5 Williams %R
    PDS Biotechnology Corp Daily Williams %R ChartPDS Biotechnology Corp Daily Williams %R Chart

    3. Volatility Indicators

    3.1 Bollinger Bands
    PDS Biotechnology Corp Daily Bollinger Bands ChartPDS Biotechnology Corp Daily Bollinger Bands Chart
    3.2 Average True Range (ATR)
    PDS Biotechnology Corp Daily Average True Range (ATR) ChartPDS Biotechnology Corp Daily Average True Range (ATR) Chart

    4. Volume Indicators

    4.1 On-Balance Volume (OBV)
    PDS Biotechnology Corp Daily On-Balance Volume (OBV) ChartPDS Biotechnology Corp Daily On-Balance Volume (OBV) Chart
    4.2 Money Flow Index (MFI)
    PDS Biotechnology Corp Daily Money Flow Index (MFI) ChartPDS Biotechnology Corp Daily Money Flow Index (MFI) Chart

    5. Summary

    5.1. Notifications

    TypeNotificationDate
    PenkeCurrently no notifications for PDS Biotechnology Corp.

    5.2. Trading Signals

    DateIndicatorEntry signalExit signal
    2023-05-18 00:00:00ATR SHORT ENTRY LONG CLOSE
    2023-05-22 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
    ATR SHORT ENTRY LONG CLOSE
    2023-05-23 00:00:00CMO LONG ENTRY SHORT CLOSE50 crossover to upside
    ATR LONG ENTRY SHORT CLOSE
    2023-05-24 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
    WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
    ATR LONG ENTRY SHORT CLOSE
    2023-05-25 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
    STOCH SHORT ENTRY LONG CLOSE80 crossover to downside
    ATR SHORT ENTRY LONG CLOSE
    MFI20 crossover to downside

    5.2. Technical Score

    Let's check the technical score of PDS Biotechnology Corp based on Penke's default Symbol scanner.

    Penke's Symbol Scanner

      
      
    IndicatorConditionValue
    RsiGreater than5066.929
    Ma 20Greater thanMa 506.620
    Ma 50Greater thanMa 1005.998
    Ma 100Greater thanMa 2006.919
    OpenGreater thanClose7.790
    Total3/5 (60.0%)

    Comments

    Join the conversation.

    Leave a comment

    Stay informed about PDS Biotechnology Corp.

    Receive notifications about PDS Biotechnology Corp in your mailbox!

    Penke's Market Notifications
    SLUS.XETRA
    1 minute ago

    I found you a Golden Cross on the daily chart of SLUS.XETRA.

    SLUS.XETRA Daily Candlestick Chart
    IXIC.INDX
    3 minutes ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of IXIC.INDX.

    IXIC.INDX Daily Candlestick Chart
    PRAU.XETRA
    3 minutes ago

    I found you a Golden Cross on the daily chart of PRAU.XETRA.

    PRAU.XETRA Daily Candlestick Chart
    PRAB.XETRA
    3 minutes ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of PRAB.XETRA.

    PRAB.XETRA Daily Candlestick Chart
    P500.XETRA
    5 minutes ago

    I found you a Golden Cross on the daily chart of P500.XETRA.

    P500.XETRA Daily Candlestick Chart
    AVVA.INDX
    12 minutes ago

    I found you a STOCH Bearish Hidden Divergence on the daily chart of AVVA.INDX.

    AVVA.INDX Daily Candlestick Chart
    DJU.INDX
    12 minutes ago

    I found you a Oversold RSI (Relative Strength Index) on the daily chart of DJU.INDX.

    DJU.INDX Daily Candlestick Chart
    ADVN.INDX
    12 minutes ago

    I found you a MACD Bearish Reversal Divergence on the daily chart of ADVN.INDX.

    ADVN.INDX Daily Candlestick Chart
    SPFU.XETRA
    47 minutes ago

    I found you a Golden Cross on the daily chart of SPFU.XETRA.

    SPFU.XETRA Daily Candlestick Chart
    XMLC.XETRA
    53 minutes ago

    I found you a Golden Cross on the daily chart of XMLC.XETRA.

    XMLC.XETRA Daily Candlestick Chart
    JCHE.XETRA
    55 minutes ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of JCHE.XETRA.

    JCHE.XETRA Daily Candlestick Chart
    NK4L.XETRA
    55 minutes ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of NK4L.XETRA.

    NK4L.XETRA Daily Candlestick Chart
    METV.XETRA
    1 hour ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of METV.XETRA.

    METV.XETRA Daily Candlestick Chart
    KTN.XETRA
    1 hour ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of KTN.XETRA.

    KTN.XETRA Daily Candlestick Chart
    ECMS.XETRA
    1 hour ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of ECMS.XETRA.

    ECMS.XETRA Daily Candlestick Chart
    XDPU.XETRA
    1 hour ago

    I found you a Golden Cross on the daily chart of XDPU.XETRA.

    XDPU.XETRA Daily Candlestick Chart
    JCGA.LSE
    1 hour ago

    I found you a Oversold RSI (Relative Strength Index) on the daily chart of JCGA.LSE.

    JCGA.LSE Daily Candlestick Chart
    JCAS.LSE
    1 hour ago

    I found you a Oversold RSI (Relative Strength Index) on the daily chart of JCAS.LSE.

    JCAS.LSE Daily Candlestick Chart
    JCAP.LSE
    1 hour ago

    I found you a Oversold RSI (Relative Strength Index) on the daily chart of JCAP.LSE.

    JCAP.LSE Daily Candlestick Chart
    SZU.XETRA
    1 hour ago

    I found you a Oversold RSI (Relative Strength Index) on the daily chart of SZU.XETRA.

    SZU.XETRA Daily Candlestick Chart
    EQQD.LSE
    1 hour ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of EQQD.LSE.

    EQQD.LSE Daily Candlestick Chart
    H4ZN.XETRA
    1 hour ago

    I found you a Golden Cross on the daily chart of H4ZN.XETRA.

    H4ZN.XETRA Daily Candlestick Chart
    CBUN.XETRA
    1 hour ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of CBUN.XETRA.

    CBUN.XETRA Daily Candlestick Chart
    DRGG.LSE
    1 hour ago

    I found you a Oversold RSI (Relative Strength Index) on the daily chart of DRGG.LSE.

    DRGG.LSE Daily Candlestick Chart
    I500.XETRA
    1 hour ago

    I found you a Golden Cross on the daily chart of I500.XETRA.

    I500.XETRA Daily Candlestick Chart